08.10.2015 • NewsDede WillamsBPShutdown & Turnaround

BP to Permanently Close Texas PX unit

BP has announced it will shutter its paraxylene (PX) plant at Texas City in the US with a capacity believed to exceed 1million t/y. The UK-based company cites market conditions as a reason for closing the plant.

BP will continue to operate its two other PX units in the US.

Without providing details the company said that following the closure of the PX facility it plans to reorganize its Texas City Chemicals plant to “better align and scale resources to meet our commitments and support our business goals, while maintaining safe, compliant and reliable operations.”

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read